David M. Goldstein - 18 Feb 2025 Form 4 Insider Report for ALUMIS INC. (ALMS)

Role: Chief Scientific Officer
Signature: /s/ Sara Klein, Attorney-in-Fact
Issuer symbol: ALMS
Transactions as of: 18 Feb 2025
Transactions value $: $0
Form type: 4
Filing time: 20 Feb 2025, 18:30:07 UTC
Previous filing: 01 Jul 2024
Next filing: 31 Jul 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ALMS	Common Stock						208K	18 Feb 2025	By Trust	F1, F2
holding	ALMS	Common Stock						8.99K	18 Feb 2025	By Family Members	F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ALMS	Stock Option (Right to Buy)	Award	$0	+180K		$0.00	180K	18 Feb 2025	Common Stock	180K	$5.06	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Holdings have been updated to include an exempt gift transfer of an aggregate of 6,000 shares on November 26, 2024 by the Baily Goldstein Living Trust dated March 4, 2014 to family members of Reporting Person residing in his primary residence.
F2	Shares are held directly by the Baily Goldstein Living Trust dated March 4, 2014, for which the Reporting Person serves as a trustee.
F3	Shares are held directly by family members of Reporting Person residing in his primary residence.
F4	25% of the shares underlying this option vest on February 18, 2026, and the remaining shares vest in equal monthly installments thereafter over the following 36 months, subject to acceleration and the Reporting Person's continuous service to the Issuer on each such vesting date.